S. Rumpler

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family

Cancer Metastasis: Building a Framework

Neuroblastoma: biological insights into a clinical enigma

Selective elimination of acentric double minutes from cancer cells through the extrusion of micronuclei

Contribution of molecular genetic data to the classification of sarcomas

Morphologic features of neuroblastoma (Schwannian stroma‐poor tumors) in clinically favorable and unfavorable groups

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

Coming of age: ten years of next-generation sequencing technologies

Neuroblastoma

Cytokinesis-block micronucleus cytome assay

A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin

De novo assembly of the Aedes aegypti genome using Hi-C yields chromosome-length scaffolds

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma

Rapid detection of structural variation in a human genome using nanochannel-based genome mapping technology

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.

Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation—sign of tumour cell revertance?

Demonstration of the translocation der(16)t(1;16)(q12;q11.2) in interphase nuclei of ewing tumors

Visualization of episomal and integrated Epstein‐Barr virus DNA by fiber fluorescence in situ hybridization

Intratumoural heterogeneity of 1p deletions andMYCN amplification in neuroblastomas

Neuroblastoma cells provoke Schwann cell proliferation in vitro

Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors